GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,175,000 | -0.1% | 72,930 | -0.0% | 0.47% | +13.5% |
Q1 2022 | $3,177,000 | +28.6% | 72,940 | +30.2% | 0.42% | +27.2% |
Q4 2021 | $2,470,000 | +13.6% | 56,007 | -1.6% | 0.33% | +4.5% |
Q3 2021 | $2,174,000 | -0.5% | 56,896 | +3.7% | 0.31% | +17.7% |
Q2 2021 | $2,184,000 | +1782.8% | 54,867 | +1585.6% | 0.27% | +1300.0% |
Q1 2021 | $116,000 | +6.4% | 3,255 | +8.9% | 0.02% | -17.4% |
Q4 2020 | $109,000 | -99.4% | 2,988 | +472.4% | 0.02% | +76.9% |
Q1 2020 | $19,790,000 | -13.5% | 522 | 0.0% | 0.01% | -7.1% |
Q4 2019 | $22,866,000 | – | 522 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |